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Summary. The neulc-erbB-2 oncogen encodes a 185 
kDa protein closely homologous to the epidermal growth 
factor receptor. The protein product (p185) is a glyco- 
protein with an external domain and an internal domain 
with tyrosine kinase activity. Amplification and/or 
overexpression of p185 is related to several human 
adenocarcinomas. Subsequent studies demonstrated its 
presence in certain neuroendocrine (NE) neoplasms, 
including phaeochromocytomas. insulinomas and 
medullary thyroid carcinomas. However, relatively little 
is known about its role in normal cell growth regulation 
and development.  Therefore, our objetive was to  
determine whether neulc-erbB-2 was expressed in 
normal NE tissues of different mammals, specially in 
humans, as it was in their neoplasms. We have examined 
by immunohistochemistry different endocrine glands 
(thyroid, pancreas, suprarrenal and hypophysis) and the 
small intestine of human beings, rats and guinea pigs, 
using two polyclonal antibodies raised against the 
intracytoplasmic part of the protein, and specific antigen 
absorption controls. We have found that a neulc-erbB-2- 
like product occurs in all normal NE tissues examined: C 
cells of the thyroid gland, chromaffin cells of the adrenal 
medulla, pancreatic islets, enteroendocrine cells of the 
small intestine and, finally, scattered cells of the 
adenohypophysis, according to a typical granular 
immunohistochemical pattern. Our results indicate that 
normal NE cells share a new common antigen in their 
cytoplasms, a neulc-erbB-2-like product, with a similar 
immunostaining pattern to  that presented by the 
neoplasms derived from them. 
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Introduction 
The neu oncogene was first described in rat neuro- 
blastomas, induced by treatment with ethylnitrosourea 
(Schechter et al., 1984). The human version of the neu 
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oncogene is also known as c-erbB-2 or HER-2. This 
oncogene encodes a 185-kDa protein closely homo- 
logous to, but different from, the epidermal growth 
factor receptor (Bargmann et al., 1986; Dougall et al., 
1994). The protein product, termed p185, is a glyco- 
protein with an extracellular ligand-binding domain, a 
transmembrane anchoring domain and an intracellular 
domain with tyrosine kinase activity (Coussens et al., 
1985). 
Much of our understanding of the physiological 
function of p185 is derived from observations in 
transformed cells. Thus, the expression of p185 is 
necessary for maintenance of the malignant phenotype 
of cell lines transformed by neu (Drebin et al., 1986). In 
addition, many studies have demonstrated amplification 
and/or overexpression of c-erbB-2 in several human 
adenocarcinomas, including those of breast and ovary 
(Slamon et al.. 1989), pancreas (Hall et al., 1990) and 
urinary bladder (Coombs et al., 1991). However, 
relatively little is known about its role in normal cell 
growth regulation and tissue development. Several 
studies have been performed to determine specific 
expression of p185 in normal mammalian fetal and adult 
tissues. Kokai et al. (1987) have shown that the neu gene 
is expressed during normal development in the rat in a 
tissue- and stage-specific manner. p185 could be 
detected in neural and connective tissue during a 
relatively short embryonic period, but in several 
epithelia] tissues expression of neu gene persisted into 
adulthood. In rats and humans, studies have reported 
expression of p185 in fetal and adult kidney (De Potter 
et al., 1987; Press et al., 1990), intestine (Quirke et al., 
1989; Press et al., 1990) and female reproductive tract 
(De Potter et al., 1987; Quirke et al., 1989). The results 
of these s tudies  imply that p185 has specialized 
functions in development and growth regulation of 
normal cells. 
Nevertheless, none of the previous studies have 
analysed the expression of p185 in normal NE tissues, a 
subject of considerable interest taking into account that 
most of them are epithelial tissues with neural origin. 
Recently, overexpression of c-erbB-2 has been reported 
in several NE tumours, such as insulinomas, pulmonary 
atypical carcinoids and phaeochromocytomas (Roncalli 
et al., 1991; Castilla-Guerra et al., 1997). Our laboratory 
has a150 identified a significant p185 expression in all 
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medullary thyroid carcinomas (Utrilla et al., 1999). 
Surprisingly, the immunohistochemical pattern of c- 
erbB-2 reactivity in all these NE tumours varied from 
the typical pattern found in adenocarcinomas -membrane 
and diffuse cytoplasmatic patterns- (Slamon et al., 1989) 
and in the normal mammalian tissues from which those 
tumours are derived -cytoplasmic pattern- (Kokai et al., 
1987; Quirke et al., 1989; Press et al., 1990). NE 
tumours showed a granular cytoplasmic immuno- 
reactivity with the antibody raised against the terminal 
part of the intracytoplasmic domain of the c-erbB-2 
oncoprotein, the same pattern presented by the central 
nervous system according to Stieber (1995) in adult rats. 
To elucidate the potential biological function of the 
c-crbB-2 oncoprotein in normal NE cells and their 
neoplasias, we sought to determine whether the neulc- 
erbB-2 gene is expressed in different NE mammalian 
tissues. Using an immunohistochemical technique and 
different antibodies, we have demonstrated that all NE 
tissues that have been investigated presented an evident 
neulc-erbB-2-like immunoreactivity with a typical 
granular cytoplasmic pattern, whose possible meaning is 
discussed in the present paper. 
Materials and methods 
Tissue samples 
We have studied normal adult thyroid, pancreas, 
suprarrenal and pituitary glands and small intestine of 
human beings, rats and guinea pigs. Furthermore, we 
have also studied human fetal thyroid glands. The 
samples were fixed either in 10% formalin, in 4% 
paraformaldehyde or in Bouin's solution and embedded 
in paraffin. 
lmmunohistochemistry 
Two antibodies were used: (1) Rabbit antibody 
raised against the intracytoplasmic part of the human c- 
erbB-2 oncoprotein (A-485, DAKO, Denmark), at a 
dilution of 111000-112000; and (2) rabbit antibody raised 
against a peptide (residues 866-873) from the kinase 
domain of the human c-neu gene product (c-neu (Ab-l), 
Oncogene Science, MA, USA), at a dilution of 11100. 
The c-erbB-2 oncoprotein was demonstrated by a 
three-stage streptavidin-biotin complex immuno- 
peroxidase technique. Sections were cut at 5 micro- 
meters thick, mounted on slides coated with 3-amino- 
propyltriethoxysilane (Sigma, USA), and then dried at 
60 "C for 1 h to promote adherence to the slide. After 
deparaffination and rehydration, a microwave oven 
pretreatment for antigen retrieval was carried out before 
immunostaining (Shi et al., 1991). The slides were 
transferred to a plastic Coplin jar filled with citrate 
buffer O.lM, pH 6, and covered with a cap to minimise 
evaporation. Four Coplin jars were placed, evenly 
spaced, in a domestic microwave oven (Toshiba, ER 
68608W) and irradiated for 4 min at 750 W power, and 
this cycle was repeated up to three times. After heating, 
the slides were allowed to cool to room temperature for 
15 min. After a short rinse in PBS (0.01M phosphate- 
buffered saline, pH 7.2), the sections were treated with 
3% hydrogen peroxide in distilled water for inhibition of 
endogenous peroxidase activity, washed in PBS, and 
then sequentially incubated with normal serum (Operon, 
Spain)  diluted 1 :10  in PBS (for 20 min at room 
temperature), specific antiserum (overnight at 4 T), 
biotinylated antiserum to rabbitlmouse immunoglobulins 
(DAKO, LSAB 2 kit, CA, USA) for 30  min, and 
streptavidin-biotin-peroxidase complex (DAKO, LSAB 
2 kit, CA, USA) for 30 min. Washing in PBS (three 
changes of 3 min each) was performed after antiserum 
incubations. Peroxidase activity was developed with 
diaminobenzidine tetrahydrochloride substrate (Sigma, 
USA). Sections were then counterstained with 
haematoxylin, dehydrated, cleared, and mounted. When 
immunopositive cells appeared, their NE character was 
confirmed in subsequent sections by using anti- 
calcitonin (only in the thyroid gland) or anti- 
chromogranin antibodies (DAKO, Denmark). 
Positive control sections (breast carcinoma) were 
included in each bath of slides to ensure consistent 
immunostaining results. Specific controls included 
substitution of primary antibody with pre-immune serum 
from the same animal and prior absorption of the 
primary antibodies with the respective immunising 
peptides (courtesy of DAKO, Denmark; c-neu Peptide-l, 
Oncogene Science, MA, USA) at room temperature for 2 
h. 
Results 
All NE human tissues investigated in the present 
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Fig. 1. lrnrnunohistochernical demonstration of a neu/c-erbB9-like product in a human thyroid gland of an adult. Note uniform, granular irnrnunostaining 
of the entire C-cell population and negativity of thyroid follicles and strorna. The tissue was fixed in forrnalin and immunostained with the DAKO 
antibody. A, X 200; B, X 1,000. 
Fig. 2. High power view of a fetal human thyroid gland. C cells are prominent and uniformly granular irnrnunostained. The tissue was fixed in formalin 
and irnrnunostained with the c-erbB-2 DAKO antibody. X 1,000 
Fig. 3. Section of the thyroid gland of a guinea pig. C cells are delicately irnrnunostained showing a diffuse granular pattern. The tissue was fixed in 
paraforrnaldehyde and irnrnunostained with the c-erbB-2 Oncogene antibody. X 400 
Fig. 4. Section of the suprarrenal gland of a human being. All chrornaffin cells show a conspicuous immunoreactivity in contrast with the negativity of 
the adrenal cortex. Higher magnification of the adrenal medulla reveals a diffuse granular pattern. The tissue was fixed in forrnalin and immunostained 
with the c-erbB-2 DAKO antibody. A, X 200; B, X 400 
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study showed a conspicuous immunostaining for the 
polyclonal c-erbB-2 antibody manufactered by DAKO 
(Table 1). The immunoreactive cells presented a 
prominent granular cytoplasmatic pattern. C cells were 
immunostained both in adult and fetal thyroid glands and 
showed a dark c-erbB-2-like product distributed as a 
punctate material diffusely in the cytoplasm (Figs. 1, 2). 
A similar immunohistochemical pattern was presented 
by apparently all pancreatic endocrine cells (Fig. 9), 
enteroendocrine cells of the small intestinal epithelium 
(Figs. 7, 8), scattered cells on the adenohypophysis (Fig. 
5 )  and, finally, the chromaffin cells of the adrenal 
medula (Fig. 4). The nervous myenteric plexus located 
in the small intestinal wall also presented a granular 
immunostaining pattern coinciding with the soma of 
ganglion cells or diffusely around them, which may be 
suggestive of synaptic localizations. A similar 
immunohistochemical pattern was found in thyroid, 
pancreas and small intestine after applying the 
polyclonal antibody raised against the peptide (residues 
866-873) of the internal domain of the c-neu product 
(Oncogene). However, the material showed a lower 
intensity. 
In regard to adult NE tissues of the rat, an evident 
immunoreactivity was only found in scattered cells of 
the adenohypophysis, when the gland was fixed in 
Bouin's solution and immunostained with the DAKO 
antibody (Fig. 6). Furthermore, a faint immunopositivity 
was also observed in C cells of the thyroid gland fixed in 
paraformaldehyde and immunostained with the 
polyclonal antiserum produced by Oncogene. 
Table 1. neu/c-erbB-2-like expression in mammalian adult NE tissues 
using DAKO antibody. 
NE TISUES HUMANS RATS GUINEA PIGS 
Thyroid: C cells ++++ 
Pancreas: islets ++++ + 
Small intestine: 
enteroendocrine cells ++++ +++ 
Adrenal medulla ++++ ++ 
Pituitary gland ++++ + + N.D.* 
N.D.: non determined. 
Finally, all NE tissues of the guinea pigs showed a 
certain degree of immnunopositivity, either using the 
DAKO antibody (pancreas, small intestine and adrenal 
medula) or Oncogene antibody (thyroid, pancreas and 
small intestine), but the second ones were always less 
intensive (Fig. 3). 
All the granular immunostainings disappeared 
completely after adding the free peptides against which 
both antibodies, DAKO and Oncogene, were raised, 
respectively. 
To exclude the possibility that the immunization 
peptides could exhibit certain homology to other known 
peptides or proteins, we have introduced their sequences 
in a protein database (SWISS-PROTITrEMBL). As a 
result of this examination only the expected 
coincidences with proteins belonging to the EGF- 
Receptor family appeared, as c-erbB-2 is a member of 
this family. No sequence homology with synaptophysin 
or chromo-granin was found. Nevertheless, we cannot 
completely exclude that the antibodies used in the 
present study do not crossreact with those proteins that 
are highly expressed in many NE cells. However, this 
possibility is inherent to the immunohistochemical 
techniques in general. 
Discussion 
In the present study the existence of neu product in 
different NE tissues from diverse mammals has been 
studied, finding a variable immunoreactivity with a 
granular cytoplasmic pattern in the thyroid C cells, the 
pancreatic endocrine islets,  the enteroendocrine 
intestinal cells, scattered cells in the adenohypophysis 
and, finally, the chromaffin cells of the suprarenal gland. 
The immunostaining was mainly obtained with the 
rabbit polyclonal antiserum raised against the terminal 
part of the internal domain of c-erhB-2 human 
oncoprotein (DAKO), being completely abolished after 
absorption with the immunising peptide (courtesy of 
DAKO). It is the first time that an exhaustive study of 
neu product in normal adult and fetal NE tissues has 
been carried out and that the existence of neulc-erbB-2- 
like immunoreactivity in these has been confirmed. 
The neu oncogene was first identified as a 
tranforming gene in chemically-induced neuroglio- 
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Fig. 5. lmmunohistochemical demonstration of a neu/c-erbB-2-like product in a human pituitary gland of an adult. Note the presence of numerous 
scattered cells showing an evident granular immunoreactivity. The tissue was fixed in formalin and immunostained with DAKO antibody. X 400 
Fig. 6. Section of a pituitary gland of the rat. There are scarce cells immunostained with the antibody. The tissue was fixed in Bouin's solution and 
immunostained with the c-erbB-2 DAKO antibody. X 400 
Fig. 7. lmmunohistochemical demonstration of a neu/c-erbB-2-like product in the Brunner's glands of the human duodenum. The glands present 
abundant enteroendocrine cells prominently immunostained. The tissue was fixed in formalin and immunostained with DAKO antibody. X 200 
Fig. 8. lmmunohistochemical demonstration of a neu/c-erbB-2-like product in the intestinal villi of the human duodenum. Enteroendocrine cells show a 
prominent granular immunoreactivity located at the basal cytoplasm. The tissue was fixed in formalin and immunostained with DAKO antibody. X 400 
Fig. 9. Photomicrography of human pancreatic islets from an adult. Note uniform, granular immunopositivity of the entire islets population and negativity 
of pancreatic acini and stroma. The tissue was fixed in formalin and immunostained with the c-erbB-2 DAKO antibody. A, X 200; B, X 400 
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blastomas (Schechter et al., 1984). Subsequently, 
amplification andlor overexpression of the human form 
of neu in several  human adenocarcinomas was  
demonstrated (Slamon et al., 1989; Hall et al., 1990; 
Coombs et al., 1991). Initially, an immunohistochemical 
pattern characteristically membranous of c-erbB-2 
positivity, exclusive to the tumoral cells, was described 
in those tumours, and which was correlated with the 
presence of a 185 kDa protein by means of Western blot 
analysis (De Potter et al., 1987). However, subsequent 
reports described the existence of diverse tumours 
(bladder, thyroid gland, pancreas) showing a different 
cytoplasmic immunostaining pattern, whether they 
coincided or not with the membranous pattern, which 
corresponded with a 155 kDa protein by Western blot 
analysis (Hall et al., 1990; Coombs et al., 1991; Soares 
et al., 1994). According to De Potter et al. (1987) this 
could be a neu-like cross-reacting protein or a different 
rteu oncogene product derived by alternative splicing 
from the same gene and having a different destination in 
the cell. Other authors reported that p155 may represent 
precursor forms of the c-erbB-2 molecule (Corbett et al., 
1990; Coombs et al., 1991; Soares et al., 1994), since 
inhibition of N-linked glycosylation by tunicamycin has 
been shown to produce an immunoprecipitable protein 
of 155-160 kDa in human cells which express c-erbB-2 
(Akijama et al., 1986). Nevertheless, the real meaning of 
this protein has still not been made definitely clear. 
With regard to the immunohistochemical staining 
pattern for c-erbB-2 found in the present study, the 
granular cytoplasmic pattern had not been described 
until now in any kind of tumour, except diverse NE 
neoplasias, such as phaeochromocytomas, insulinomas, 
pulmonary atypical carcinomas and, according to our 
own experience, in medullary thyroid carcinoma 
(Roncalli et al., 1991; Castilla-Guerra et al., 1997; 
Utrilla et al., 1999). Considering all results together, we 
can assert that both normal and tumoral NE cells share 
the same pattern for c-erbB-2 immunoreactivity. The 
meaning of the granular cytoplasmic patterm may be the 
same as for the diffuse cytoplasmic pattern described by 
De Potter et al. (1987), a neu-like cross-reacting protein. 
Alternatively, it may represent membrane traffic of the 
newly synthesized protein, since immunoelectron 
microscopic studies have shown the presence of c-erbB- 
2 immunoreactivity in cytoplasmic elements such as 
endoplasmic reticulum (Mori et al., 1987) or  in 
endosomal compartments (Miller et al., 1986). 
Nevertheless,  we  are tempted to suggest  an 
alternative explanation for this. Recently, Stieber et al. 
(1995) described the presence of a p140 kDa protein in 
membrane synaptosomes of rat central nervous system 
using a polyclonal antiserum raised against the carboxy- 
terminal part of the p185 neu rat protein. The same 
antiserum reacted with a 185 kDa protein in microsome 
membranes from rat phaeochromocytoma cells. In both 
cases, the immunohistochemical pattern was finely 
granular and coincided in the central nervous system 
with synaptic localizations. The identity of the 140 kDa 
protein was unknown, but the authors suggested that it 
could be related to p185 neu protein or to other kinases. 
Considering that neural cells and NE cells share a 
common origin in the neuroectoderm, they may also 
share many differente features, as is generally accepted. 
One of the best known common features is the presence 
of synaptophysin as an immunohistochemical marker for 
both neural and NE cellular systems. Synaptophysin is 
found in synaptic vesicles (Jahn et al., 1985), in adrenal 
chromaffin granules and in secretory granules of all NE 
cells (Gould et al., 1986; Buffa et al., 1987). In fact, 
parafollicular cell granules have been considered 
analogous to the synaptic vesicles of serotonergic 
neurons (Barash et al., 1987). Weiler et al. (1989) have 
also described other common membrane antigens in 
vesicles obtained from neural crest-derived endocrine 
cells, like cytochrome b-561 and carboxypeptidase H, 
enzyme involved in the processing of peptides. As 
happens with synaptophysin and these other antigens, a 
rteulc-erbB-2-like product may be shared by synaptic 
vesicles, chromaffin granules and secretory granules of 
NE cells. 
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